Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

THOMAS J LANG

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1457312332
CMS profile
65284
Location
COLUMBIA, MD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$4,235.02

187 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,379.61 183
Travel and Lodging $855.41 4

By paying entity

PY2020 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 187 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

THOMAS J LANG

NPI 1457312332 · CMS profile ID 65284

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

COLUMBIA, MD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 187 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1457312332?year=2020&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
THOMAS J LANG, NPI 1457312332, CMS profile ID 65284. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 187 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1457312332?year=2020&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). THOMAS J LANG, NPI 1457312332, CMS profile ID 65284. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 187 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1457312332?year=2020&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
THOMAS J LANG, NPI 1457312332, CMS profile ID 65284, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 187 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1457312332?year=2020&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

187 matching records · $4,235.02 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 187 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 187.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AbbVie Inc. $21.8107/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721972765 CMS
Janssen Biotech, Inc. $16.6207/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719452819 CMS
Mallinckrodt Hospital Products Inc. $19.4407/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751706687 CMS
UCB, Inc. $18.0707/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746065233 CMS
UCB, Inc. $0.2907/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746111533 CMS
Radius Health, Inc. $21.1606/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746298477 CMS
UCB, Inc. $16.1106/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746069441 CMS
Novartis Pharmaceuticals Corporation $15.7206/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725986953 CMS
Amgen Inc. $13.0106/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741334723 CMS
GlaxoSmithKline, LLC. $14.9806/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738802179 CMS
Janssen Biotech, Inc. $21.6206/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719452805 CMS
Mallinckrodt Hospital Products Inc. $28.2906/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751706685 CMS
Novartis Pharmaceuticals Corporation $14.9506/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725986951 CMS
Horizon Therapeutics plc $29.4606/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721414521 CMS
AbbVie Inc. $24.0006/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721972760 CMS
Mallinckrodt Hospital Products Inc. $15.9806/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751706683 CMS
AbbVie Inc. $21.2406/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721972757 CMS
Amgen Inc. $27.6406/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741448629 CMS
E.R. Squibb & Sons, L.L.C. $24.8506/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727834237 CMS
Radius Health, Inc. $16.9605/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746298441 CMS
AbbVie Inc. $19.8105/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721972753 CMS
Amgen Inc. $15.5705/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741334721 CMS
E.R. Squibb & Sons, L.L.C. $19.8105/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727834231 CMS
AbbVie Inc. $19.2105/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721972749 CMS
GlaxoSmithKline, LLC. $13.4205/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738756649 CMS
Janssen Biotech, Inc. $16.2505/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719452817 CMS
Horizon Therapeutics plc $26.7305/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721414519 CMS
E.R. Squibb & Sons, L.L.C. $6.8705/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727834235 CMS
Mallinckrodt Hospital Products Inc. $17.3005/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751706681 CMS
PFIZER INC. $25.4405/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743349385 CMS
AbbVie Inc. $24.0105/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721972743 CMS
UCB, Inc. $15.0205/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746055683 CMS
E.R. Squibb & Sons, L.L.C. $18.1604/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727834223 CMS
Mallinckrodt Hospital Products Inc. $30.4804/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751706679 CMS
Mallinckrodt Hospital Products Inc. $34.0804/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751706677 CMS
Horizon Therapeutics plc $15.7104/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721414517 CMS
Janssen Biotech, Inc. $17.2604/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719452815 CMS
E.R. Squibb & Sons, L.L.C. $15.2003/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727834211 CMS
Horizon Therapeutics plc $21.6503/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721414515 CMS
Lilly USA, LLC $15.6803/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728659701 CMS
Amgen Inc. $23.9603/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741448627 CMS
Alexion Pharmaceuticals, Inc. $16.3303/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726613747 CMS
UCB, Inc. $20.1103/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746075000 CMS
AbbVie Inc. $20.9303/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721972733 CMS
AbbVie Inc. $2.1703/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721972737 CMS
AbbVie Inc. $0.4203/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721972741 CMS
PFIZER INC. $14.0103/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743350045 CMS
Horizon Therapeutics plc $5.9603/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721414513 CMS
E.R. Squibb & Sons, L.L.C. $18.4203/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727834207 CMS
Novartis Pharmaceuticals Corporation $14.4002/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725986949 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,819.90 199
PY2020 $4,235.02 187
PY2021 $2,786.73 174
PY2022 $3,742.01 199
PY2023 $4,192.01 179
PY2024 $3,839.43 165
PY2025 $4,555.65 194

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Principal investigator $1,511.01 2
PY2020 Principal investigator $3,457.56 2
PY2019 Principal investigator $2,284.74 4

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

2 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $19.77 01/15/2021 Non-covered Recipient Entity
ARTHRITIS CARE SPECIALISTS
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, PHASE III MULTICENTER STUDY OF INTRAVENOUS SECUKINUMAB TO COMPARE EFFICACY AT 16 WEEKS WITH PLACEBO AND TO ASSESS SAFETY AND TOLERABILITY UP TO 52 WEEKS IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS No dispute reported 06/30/2026 800616719
Principal investigator 1 Novartis Pharmaceuticals Corporation $1,491.24 01/15/2021 Non-covered Recipient Entity
ARTHRITIS CARE SPECIALISTS
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, PHASE III MULTICENTER STUDY OF INTRAVENOUS SECUKINUMAB TO COMPARE EFFICACY AT 16 WEEKS WITH PLACEBO AND TO ASSESS SAFETY AND TOLERABILITY UP TO 52 WEEKS IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS OR NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS No dispute reported 06/30/2026 800620149